It has been well established that HIF2α, but not HIF1α, is a major oncogenic driver in ccRCC [10], as such, we reasoned that USP7 may regulate HIF2α downstream pathway. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.